Home - BJH

Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia
Zanubrutinib as a new treatment option for patients with Waldenström macroglobulinaemia
FDA approval for brentuximab vedotin for children with high-risk Hodgkin lymphoma

Amsterdam scientists investigate why immunotherapy fails in Chronic Lymphocytic Leukaemia

Pharma News

FDA approves efanesoctocog alfa for the treatment of haemophilia A

General

Highlights from the annual BSTH meeting 2022

subscribe Latest issue All issues Newsletters

Clinical practice

Clinical efficacy of non-pharmacological therapy for sickle cell disease and oncologic conditi...

Health Innovation

Wearable device for tracking temperature of paediatric blood cancer patients at home

Clinical trials

Tucidinostat, a promising therapeutic option for R/R peripheral T-cell lymphoma

Prevention

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...

Cancer-associated thrombosis awareness survey (ECPC)

Show me

Also interesting

Science

Canakinumab in children and young adults with sickle cell anaemia

Clinical practice

Long-term remission rates after treatment with tisagenlecleucel in paediatric and young adult ...

Clinical trials

Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients

Health Innovation

New Danish app helps doctors in making better decisions for leukaemia patients

Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia

Zanubrutinib as a new treatment option for patients with Waldenström macroglobulinaemia

FDA approval for brentuximab vedotin for children with high-risk Hodgkin lymphoma

Recommended

Science

Amsterdam scientists investigate why immunotherapy fails in Chronic Lymphocytic Leukaemia

Pharma News

FDA approves efanesoctocog alfa for the treatment of haemophilia A

General

Highlights from the annual BSTH meeting 2022

Clinical practice

Clinical efficacy of non-pharmacological therapy for sickle cell disease and oncologic conditi...

Health Innovation

Wearable device for tracking temperature of paediatric blood cancer patients at home

Clinical trials

Tucidinostat, a promising therapeutic option for R/R peripheral T-cell lymphoma

Prevention

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...

Cancer-associated thrombosis awareness survey (ECPC)

Also interesting

Science

Canakinumab in children and young adults with sickle cell anaemia

Clinical practice

Long-term remission rates after treatment with tisagenlecleucel in paediatric and young adult ...

Clinical trials

Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients

Health Innovation

New Danish app helps doctors in making better decisions for leukaemia patients